- Investigator
- James Wymer
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- Amyotrophic Lateral Sclerosis , 28 publications
- Deglutition Disorders , 10 publications
- Deglutition , 9 publications
- Disease Progression , 5 publications
Research activity
Active clinical trials
The purpose of this study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of NMD670 in the treatment of ambulatory adults with spinal muscular atrophy type 3
- Investigator
- James Wymer
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All
The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.
- Investigator
- James Wymer
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
My publications
Filter publications
47 publications
2023
Pharmacokinetics, Bioavailability, and Swallowing Safety With Riluzole Oral Film.
Clinical pharmacology in drug development
PubMed • Publisher's site2023
Predictors of Peak Expiratory Cough Flow in Individuals with Amyotrophic Lateral Sclerosis.
Dysphagia
PubMed • Publisher's site2023
Primary lateral sclerosis natural history study - planning, designing, and early enrollment.
Amyotrophic lateral sclerosis & frontotemporal degeneration
PubMed • Publisher's site2023
Profiles of Dysarthria and Dysphagia in Individuals With Amyotrophic Lateral Sclerosis.
Journal of speech, language, and hearing research : JSLHR
PubMed • Publisher's site2023
Profiling Number of Swallows per Bolus and Residue in Individuals With Amyotrophic Lateral Sclerosis.
Journal of speech, language, and hearing research : JSLHR
PubMed • Publisher's site